CORRECTION article

Front. Endocrinol., 15 April 2025

Sec. Adrenal Endocrinology

Volume 16 - 2025 | https://doi.org/10.3389/fendo.2025.1593408

Corrigendum: The value of targeted CXCR4 18F-AlF-NOTA-pentixafor PET/CT for subtyping primary aldosteronism

  • 1. Department of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

  • 2. Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

  • 3. The First School of Clinical Medicine, Wenzhou Medical University, Wenzhou, China

  • 4. Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

  • 5. Department of Interventional Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

  • 6. Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

  • 7. Key Laboratory of Intelligent Treatment and Life Support for Critical Diseases of Zhejiang Province, Wenzhou, China

  • 8. Key Laboratory of Novel Nuclide Technologies on Precision Diagnosis and Treatment & Clinical Transformation of Wenzhou City, Wenzhou, China

In the published article, there was an error in Figure 7 as published. We mistakenly exported and uploaded this figure. The corrected Figure 7 and its caption appear below.

Figure 7

In the published article, there was an error in section 2. Materials and Methods, Adrenal Venous Sampling Interpretation, Paragraph 1. The following sentence was removed.

“If the ratio of aldosterone/cortisol in the high-side adrenal vein blood to the low-side adrenal vein blood is 4 or greater, it indicates increased aldosterone secretion from one side of the adrenal gland, which is diagnosed as APA.”

In the published article, there was an error in section 3. Results, Diagnostic Accuracy of 18F-AlF-NOTA-pentixafor PET/CT for surgically eligible lesions, Paragraph 1. The following sentence was removed.

“Among enrolled patients, 2 UPA patients exhibited 2 hot nodules in the ipsilateral adrenal gland, 2 UPA patients exhibited a cold lesion contralateral to the UPA lesion, and 3 NFA patients exhibited bilateral nodules. The remaining 81 patients displayed unilateral adrenal gland lesions on CT scans.”

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

primary aldosteronism, CXCR4, 18 F-pentixafor, PET/CT, subtyping, treatment

Citation

Peng Y, Chen F, Yao R, Lan J, Fu Y, Ye K, Wang Z, Zhao Q, Ji X, Xia K, Zhu G, Zheng K, Gu X and Tang K (2025) Corrigendum: The value of targeted CXCR4 18F-AlF-NOTA-pentixafor PET/CT for subtyping primary aldosteronism. Front. Endocrinol. 16:1593408. doi: 10.3389/fendo.2025.1593408

Received

14 March 2025

Accepted

26 March 2025

Published

15 April 2025

Volume

16 - 2025

Edited and reviewed by

Henrik Falhammar, Karolinska Institutet (KI), Sweden

Updates

Copyright

*Correspondence: Xuemei Gu, ; Kun Tang,

†These authors have contributed equally to this work and share last authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics